Clinical practice for unspecified anxiety disorder in primary care.
Hitoshi SakuraiMasahiro TakeshimaKen InadaYumi AokiKenya IeMorito KiseEriko YoshidaTakashi TsuboiHisashi YamadaHikaru HoriYasushi InadaEiji ShimizuKazuo MishimaKoichiro WatanabeYoshikazu TakaesuPublished in: PCN reports : psychiatry and clinical neurosciences (2023)
Primary care physicians exercise caution when prescribing benzodiazepine anxiolytics for unspecified anxiety disorder. Nonpharmacological interventions and switching to SSRI are modestly employed as primary treatment options and alternatives to benzodiazepine anxiolytics. To ensure the safe and effective treatment of unspecified anxiety disorder in primary care, more information should be provided from field experts.